303 related articles for article (PubMed ID: 11190289)
1. [Treatment of arterial hypertension in the elderly].
Girerd X; Hanon O
Arch Mal Coeur Vaiss; 2000 Nov; 93(11 Suppl):1411-6. PubMed ID: 11190289
[TBL] [Abstract][Full Text] [Related]
2. [Benefits of hypertension treatment in the elderly].
Girerd X; Hanon O
Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):518-22. PubMed ID: 12555376
[TBL] [Abstract][Full Text] [Related]
3. Diuretics for cardiovascular prevention in the elderly.
Hanon O; Seux ML; Lenoir H; Rigaud AS; Girerd X; Forette F
J Hum Hypertens; 2004 Dec; 18 Suppl 2():S15-22. PubMed ID: 15592568
[TBL] [Abstract][Full Text] [Related]
4. [Cardiac protection and antihypertensive therapy: facts and theories].
Verdecchia P
Minerva Med; 1986 Jun; 77(26):1259-70. PubMed ID: 3523304
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
[TBL] [Abstract][Full Text] [Related]
6. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
[TBL] [Abstract][Full Text] [Related]
7. Does the benefit of antihypertensive treatment outweigh the risk in very elderly hypertensive patients?
Forette F; Lechowski L; Rigaud AS; Seux ML; Dessi F; Forette B
J Hypertens Suppl; 2000 Jul; 18(3):S9-12. PubMed ID: 10952082
[TBL] [Abstract][Full Text] [Related]
8. ESH-ESC guidelines for the management of hypertension.
Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
[TBL] [Abstract][Full Text] [Related]
9. Hypertension in the elderly: new and old evidence that treatment may benefit the old.
Fagard RH
J Nephrol; 2009; 22(5):580-6. PubMed ID: 19809990
[TBL] [Abstract][Full Text] [Related]
10. Hypertension in the elderly.
Coope J
J Hypertens Suppl; 1987 Aug; 5(3):S69-72. PubMed ID: 3312529
[TBL] [Abstract][Full Text] [Related]
11. [Antihypertensive therapy in the elderly: results of large trials].
Leonetti G; Cuspidi C; Facchini M
Ital Heart J Suppl; 2001 Nov; 2(11):1161-9. PubMed ID: 11775407
[TBL] [Abstract][Full Text] [Related]
12. Optimal treatment of hypertension in the elderly: a Korean perspective.
Kim KI; Cho YS; Choi DJ; Kim CH
Geriatr Gerontol Int; 2008 Mar; 8(1):5-11. PubMed ID: 18713183
[TBL] [Abstract][Full Text] [Related]
13. 'Beyond blood pressure' means multiple risk factor intervention, not pleiotropic antihypertensive drugs.
Staessen JA; Thijs L; Li Y; Kuznetsova T; Richart T; Wang J; Birkenhäger WH
Curr Opin Cardiol; 2007 Jul; 22(4):335-43. PubMed ID: 17556887
[TBL] [Abstract][Full Text] [Related]
14. Rationale, design and patient baseline characteristics of OlmeSartan and calcium antagonists randomized (OSCAR) study: a study comparing the incidence of cardiovascular events between high-dose angiotensin II receptor blocker (ARB) monotherapy and combination therapy of ARB with calcium channel blocker in Japanese elderly high-risk hypertensive patients (ClinicalTrials. gov no. NCT00134160).
Ogawa H; Kim-Mitsuyama S; Jinnouchi T; Matsui K; Arakawa K
Hypertens Res; 2009 Jul; 32(7):575-80. PubMed ID: 19444280
[TBL] [Abstract][Full Text] [Related]
15. Blood pressure lowering, not vascular mechanism of action, is the primary determinant of clinical outcome.
Leenen FH
Can J Cardiol; 2004 Aug; 20 Suppl B():77B-82B. PubMed ID: 15309209
[TBL] [Abstract][Full Text] [Related]
16. Hypertension in the elderly.
McCoy CE
R I Med; 1993 May; 76(5):239-42. PubMed ID: 8518499
[TBL] [Abstract][Full Text] [Related]
17. Risk stratification for the prevention of cardiovascular complications of hypertension.
Girerd X; Giral P
Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
[TBL] [Abstract][Full Text] [Related]
18. [Blood pressure parameters and cardiovascular risk in the elderly].
Blacher J; Henry O; Girerd X; Safar M
Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):489-93. PubMed ID: 12555371
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and antihypertensive drugs in the elderly.
Fletcher A; Bulpitt C
Aging (Milano); 1992 Jun; 4(2):115-23. PubMed ID: 1504127
[TBL] [Abstract][Full Text] [Related]
20. [When can the treatment of isolated systolic hypertension be avoided?].
Vischer UM; Benetos A
Rev Med Suisse; 2006 Apr; 2(60):942-6. PubMed ID: 16673726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
